287 related articles for article (PubMed ID: 29033317)
21. NMR
Sharma AK; Lee SJ; Rigby AC; Townson SA
Biomol NMR Assign; 2018 Oct; 12(2):269-272. PubMed ID: 29721757
[TBL] [Abstract][Full Text] [Related]
22. An open conformation of switch I revealed by the crystal structure of a Mg2+-free form of RHOA complexed with GDP. Implications for the GDP/GTP exchange mechanism.
Shimizu T; Ihara K; Maesaki R; Kuroda S; Kaibuchi K; Hakoshima T
J Biol Chem; 2000 Jun; 275(24):18311-7. PubMed ID: 10748207
[TBL] [Abstract][Full Text] [Related]
23. Crystal structures of the state 1 conformations of the GTP-bound H-Ras protein and its oncogenic G12V and Q61L mutants.
Muraoka S; Shima F; Araki M; Inoue T; Yoshimoto A; Ijiri Y; Seki N; Tamura A; Kumasaka T; Yamamoto M; Kataoka T
FEBS Lett; 2012 Jun; 586(12):1715-8. PubMed ID: 22584058
[TBL] [Abstract][Full Text] [Related]
24. The Structural Basis of Oncogenic Mutations G12, G13 and Q61 in Small GTPase K-Ras4B.
Lu S; Jang H; Nussinov R; Zhang J
Sci Rep; 2016 Feb; 6():21949. PubMed ID: 26902995
[TBL] [Abstract][Full Text] [Related]
25. Mechanism of free radical nitric oxide-mediated Ras guanine nucleotide dissociation.
Heo J; Prutzman KC; Mocanu V; Campbell SL
J Mol Biol; 2005 Mar; 346(5):1423-40. PubMed ID: 15713491
[TBL] [Abstract][Full Text] [Related]
26. Nucleotide based covalent inhibitors of KRas can only be efficient in vivo if they bind reversibly with GTP-like affinity.
Müller MP; Jeganathan S; Heidrich A; Campos J; Goody RS
Sci Rep; 2017 Jun; 7(1):3687. PubMed ID: 28623374
[TBL] [Abstract][Full Text] [Related]
27. Three-dimensional structure of p21 in the active conformation and analysis of an oncogenic mutant.
Wittinghofer F; Krengel U; John J; Kabsch W; Pai EF
Environ Health Perspect; 1991 Jun; 93():11-5. PubMed ID: 1773783
[TBL] [Abstract][Full Text] [Related]
28. NMR
Yuan C; Hansen AL; Bruschweiler-Li L; Brüschweiler R
Biomol NMR Assign; 2024 Jun; 18(1):7-13. PubMed ID: 37948018
[TBL] [Abstract][Full Text] [Related]
29. Revealing the mechanism of action of a first-in-class covalent inhibitor of KRASG12C (ON) and other functional properties of oncogenic KRAS by
Sharma AK; Pei J; Yang Y; Dyba M; Smith B; Rabara D; Larsen EK; Lightstone FC; Esposito D; Stephen AG; Wang B; Beltran PJ; Wallace E; Nissley DV; McCormick F; Maciag AE
J Biol Chem; 2024 Feb; 300(2):105650. PubMed ID: 38237681
[TBL] [Abstract][Full Text] [Related]
30. NMR
Sharma AK; Lee SJ; Zhou M; Rigby AC; Townson SA
Biomol NMR Assign; 2019 Apr; 13(1):227-231. PubMed ID: 30798456
[TBL] [Abstract][Full Text] [Related]
31. Biological and structural characterization of a Ras transforming mutation at the phenylalanine-156 residue, which is conserved in all members of the Ras superfamily.
Quilliam LA; Zhong S; Rabun KM; Carpenter JW; South TL; Der CJ; Campbell-Burk S
Proc Natl Acad Sci U S A; 1995 Feb; 92(5):1272-6. PubMed ID: 7877967
[TBL] [Abstract][Full Text] [Related]
32. K-Ras Populates Conformational States Differently from Its Isoform H-Ras and Oncogenic Mutant K-RasG12D.
Parker JA; Volmar AY; Pavlopoulos S; Mattos C
Structure; 2018 Jun; 26(6):810-820.e4. PubMed ID: 29706533
[TBL] [Abstract][Full Text] [Related]
33. KRAS Switch Mutants D33E and A59G Crystallize in the State 1 Conformation.
Lu J; Bera AK; Gondi S; Westover KD
Biochemistry; 2018 Jan; 57(3):324-333. PubMed ID: 29235861
[TBL] [Abstract][Full Text] [Related]
34. Nucleotide binding switches the information flow in ras GTPases.
Raimondi F; Portella G; Orozco M; Fanelli F
PLoS Comput Biol; 2011 Mar; 7(3):e1001098. PubMed ID: 21390270
[TBL] [Abstract][Full Text] [Related]
35. 2'-Deoxy Guanosine Nucleotides Alter the Biochemical Properties of Ras.
Yun SD; Scott E; Moghadamchargari Z; Laganowsky A
Biochemistry; 2023 Aug; 62(16):2450-2460. PubMed ID: 37487239
[TBL] [Abstract][Full Text] [Related]
36. High frequency (139.5 GHz) electron paramagnetic resonance characterization of Mn(II)-H2(17)O interactions in GDP and GTP forms of p21 ras.
Bellew BF; Halkides CJ; Gerfen GJ; Griffin RG; Singel DJ
Biochemistry; 1996 Sep; 35(37):12186-93. PubMed ID: 8810926
[TBL] [Abstract][Full Text] [Related]
37. X-ray crystal structures reveal two activated states for RhoC.
Dias SM; Cerione RA
Biochemistry; 2007 Jun; 46(22):6547-58. PubMed ID: 17497936
[TBL] [Abstract][Full Text] [Related]
38. Structure of an inactive conformation of GTP-bound RhoA GTPase.
Lin Y; Lu S; Zhang J; Zheng Y
Structure; 2021 Jun; 29(6):553-563.e5. PubMed ID: 33497604
[TBL] [Abstract][Full Text] [Related]
39. Nucleotide binding and GTP hydrolysis by the 21-kDa product of the c-H-ras gene as monitored by proton-NMR spectroscopy.
Löw A; Sprinzl M; Limmer S
Eur J Biochem; 1993 Apr; 213(2):781-8. PubMed ID: 8386636
[TBL] [Abstract][Full Text] [Related]
40. Molecular dynamics simulations of Gly-12-->Val mutant of p21(ras): dynamic inhibition mechanism.
Futatsugi N; Tsuda M
Biophys J; 2001 Dec; 81(6):3483-8. PubMed ID: 11721009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
